Mesoridazine and chlorpromazine in the treatment of alcohol withdrawal syndrome.
D000284:Administration, Oral; D000437:Alcoholism / Q000188:drug therapy*; D002746:Chlorpromazine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007273:Injections, Intramuscular; D008297:Male; D008653:Mesoridazine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D010672:Phenytoin / Q000008:administration & dosage; D011569:Psychiatric Status Rating Scales; D013375:Substance Withdrawal Syndrome / Q000188:drug therapy*; D014815:Vitamins / Q000008:administration & dosage
D014815:Vitamins; D008653:Mesoridazine; D010672:Phenytoin; D002746:Chlorpromazine